Stock screener

EYPT

Conviction 47IndustrialsScan · Thu, Jun 25, 2026
EYPT$13.71-4.83%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.17M
Mar 26Apr 14May 1May 19Jun 8Jun 25
EyePoint, Inc.LABORATORY ANALYTICAL INSTRUMENTSwww.eyepoint.bio
Price13.71
Change-4.83%
Gap-0.07%
Rel volume0.82×
Avg volume1.14M
Avg $ vol14.77M
SMA 2012.91
SMA 5013.26
SMA 20014.12
Price vs 50+3.38%
Price vs 200-2.97%
MA stackmixed
50/200 cross
Supertrendup · 12.16
RSI (14)55
MACD hist0.23
MACD crossbull · 8d
Stoch %K / %D67 / 80
ADX (14)12
+DI / −DI25 / 20
RSI divergence
MACD divergence
ATR %+6.08%
ADR %6.22%
52w high18.85
52w low9.41
From 52w high-27.29%
Above 52w low+45.64%
New 52w highNo
SqueezeOff
Bollinger width25.80%
%B0.74
Donchian pos67.04%
Donchian high14.89
Donchian low11.30
AVWAP (52w high)14.75
vs AVWAP high-7.08%
AVWAP (52w low)13.70
vs AVWAP low+0.07%
OBV trendUp
Chaikin MF (20)0.00
Today vs 20d0.82×
Avg vol (14d)1.17M
Avg vol (20d)1.14M
Avg $ vol (20d)14.77M
Market cap1.15B
RS 3m (vs SPY)+2.12%
RS 6m (vs SPY)-25.12%
RS line new highNo
Trend template5/8
Technical rank42.4
1 week+4.22%
1 month+2.66%
3 months+5.02%
6 months-27.29%
1 year+49.29%
YTD-21.60%
P/E-4.95
P/B4.99
P/S36.63
P/FCF-4.72
EPS-3.17
Div yield
ROE-100.65%
ROA-80.48%
Debt/Eq0.00
Current6.66
EV/EBITDA-4.44
Gross margin
Net margin-739.42%
Rev growth-27.50%
EPS growth-77.25%
Price target36.63
Target upside167.27%
Analyst ratingBuy
Institutional113.34%
Ent. value1.07B
Revenue696K
Net income-84.83M
Gross profit
Free cash flow-243.39M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out83.84M
Employees214
ListedThu, Jan 27, 2005
Free float81.36M
Float %98.3%
Short interest15.1M
Days to cover15.1d
Short volume51.5%
Squeeze score70 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.88 · 2 est
Last EPS vs est−$0.99 vs −$0.79
Last surprise-25.3% miss
Setup gradeC
Conviction47 / 100
Pattern quality
Tech rank42.4 / 100
Group rank77 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance14.45
Support11.35
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EYPT

All disclosures →
No recent disclosed trades by Congress in EYPT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EYPT · 2 buys · 4 sells

InsiderSideShares
Elston George
Chief Financial Officer · Common Stock · 2026-05-25
Tax3.63K
Elston George
Chief Financial Officer · Restricted Stock Units · 2026-05-25
Exercise7.5K
Elston George
Chief Financial Officer · Common Stock · 2026-05-25
Other
Elston George
Chief Financial Officer · Common Stock · 2026-05-25
Exercise7.5K
Ribeiro Ramiro
Chief Medical Officer · Common Stock · 2026-04-17
Sell2.44K
Ribeiro Ramiro
Chief Medical Officer · Common Stock · 2026-04-17
Exercise2.44K
Ribeiro Ramiro
Chief Medical Officer · Stock Option (Right to Buy) · 2026-04-17
Exercise2.44K

SEC filings

EDGAR filings in EYPT · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.